Qulipta (atogepant) is a medication that's used to prevent migraines in adults. The specific dosing will depend on how many migraines you have per month, but the medication is typically taken once daily. Qulipta (atogepant) is currently brand only; it isn't available as a lower-cost generic yet. Side effects include nausea, constipation, and sleepiness.
Prevention of migraines in adults
Qulipta (atogepant) is a calcitonin gene-related peptide (CGRP) receptor blocker. This means it blocks a protein called CGRP in the brain and nervous system. CGRP is thought to be involved with migraines and causing inflammation and pain. By blocking the protein's activity, Qulipta (atogepant) can help prevent migraine attacks.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Taken once per day
Can take with or without food
Can use if you have mild-to-moderate liver problems
Not used for treating a migraine attack
Unknown whether it's safe or works well in children
Hasn't been studied in pregnant women
Make sure to attend all of your follow-up appointments so your provider can determine whether the prescribed dose of Qulipta (atogepant) is working for you.
You can take Qulipta (atogepant) with or without food. If it's hurting your stomach, sometimes taking it with food can help.
Qulipta (atogepant) can make you feel sleepy or dizzy. Be sure you know how this medication affects you before driving or doing anything that requires a lot of attention.
It might be a good idea to limit or avoid drinking alcohol while you're taking Qulipta (atogepant). Both alcohol and Qulipta (atogepant) can cause sleepiness and dizziness. In addition, alcohol can raise your risk for migraines.
Let your provider know if you eat grapefruit or drink grapefruit juice regularly because they might need to adjust your Qulipta (atogepant) dose. Grapefruit can raise the amount of medication in your body, which puts you at higher risk for side effects like nausea, constipation, and sleepiness.
Make sure to tell your provider about all the medications you're taking before starting Qulipta (atogepant). This includes over-the-counter (OTC) medications and herbal supplements. Don't start any new medications while taking Qulipta (atogepant) without talking to your provider or pharmacist first. Qulipta (atogepant) interacts with a lot of medications, such as rifampin (Rifadin), carbamazepine (Tegretol), and clarithromycin. Your provider and pharmacist can check for any dangerous interactions and adjust your medications accordingly so that they're safe for you.
Qulipta (atogepant) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Allergic reactions to Qulipta (atogepant) are possible. These reactions can include facial swelling, shock, and anaphylaxis (closing of the throat), and they can sometimes be life-threatening. Reactions can happen days after you take Qulipta (atogepant). If you notice dizziness, a choking sensation, difficulty breathing, nausea, swelling around your eyes, or swelling of the lips or tongue after using Qulipta (atogepant), get medical attention right away.
Episodic migraines (migraines that occur on fewer than 15 days per month): The typical dose is 10 mg, 30 mg, or 60 mg by mouth once per day.
Chronic migraines (migraines that occur on 15 or more days per month): The typical dose is 60 mg by mouth once per day.
Your dose might differ depending on whether you're taking another medication that interacts with Qulipta (atogepant) and whether you have kidney problems.
Prevention of migraines in adults
Prevention and treatment of migraines with or without aura in adults
Migraine attacks with or without aura in adults
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
AbbVie Inc. (2023). Qulipta- atogetpant tablet [package insert].
AbbVie Inc. (2023). Qulipta- atogepant tablet [package insert]. DailyMed.
Banks, J. (n.d.). CGRP: What you need to know. National Headache Foundation.
Department of Justice/Drug Enforcement Administration. (2020). Narcotics.
Qulipta. (n.d.). How does Qulipta work within your body?
Schwedt, T. J., et al. (2022). Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial. Cephalalgia.
U.S. Food and Drug Administration. (2021). Grapefruit juice and some drugs don't mix.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.